相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In situ triggering antitumor efficacy of alcohol-abuse drug disulfiram through Cu-based metal-organic framework nanoparticles
Lin Hou et al.
ACTA PHARMACEUTICA SINICA B (2021)
Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow
Weiwei Liu et al.
ACS NANO (2021)
Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification
Wencheng Wu et al.
ADVANCED MATERIALS (2020)
Developing New Cancer Nanomedicines by Repurposing Old Drugs
Bowen Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Bone-targeted oxidative stress nanoamplifier for synergetic chemo/chemodynamic therapy of bone metastases through increasing generation and reducing elimination of ROS
Zeqian Huang et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting
Liting Ren et al.
THERANOSTICS (2020)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018)
F. Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Reactive Oxygen Species (ROS)-Based Nanomedicine
Bowen Yang et al.
CHEMICAL REVIEWS (2019)
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition
Wencheng Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Nanocarriers for drug delivery applications
Munusamy Chamundeeswari et al.
ENVIRONMENTAL CHEMISTRY LETTERS (2019)
Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor
Zeqian Huang et al.
THERANOSTICS (2019)
Copper as the Target for Anticancer Nanomedicine
Shiqun Shao et al.
ADVANCED THERAPEUTICS (2019)
Repurposing disulfiram for cancer therapy via targeted nanotechnology through enhanced tumor mass penetration and disassembly
Huacheng He et al.
ACTA BIOMATERIALIA (2018)
16-O-caffeoyl-16-hydroxylhexadecanoic acid, a medicinal plant-derived phenylpropanoid, induces apoptosis in human hepatocarcinoma cells through ROS-dependent endoplasmic reticulum stress
Huang Ri-Zhen et al.
PHYTOMEDICINE (2018)
Paraptosis-Inducing Nanomedicine Overcomes Cancer Drug Resistance for a Potent Cancer Therapy
Yongcun Zhou et al.
SMALL (2018)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
Xueqing Lun et al.
CLINICAL CANCER RESEARCH (2016)
FROM THE ANALYST'S COUCH Trends in clinical success rates
Katarzyna Smietana et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells
Lincan Duan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis
Vino T. Cheriyan et al.
PLOS ONE (2014)
The Role of Copper in Disulfiram-Induced Toxicity and Radiosensitization of Cancer Cells
Colin Rae et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
P. Liu et al.
BRITISH JOURNAL OF CANCER (2012)
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Concetta Conticello et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
NF-κB in the pathogenesis and treatment of multiple myeloma
Zhi-Wei Li et al.
CURRENT OPINION IN HEMATOLOGY (2008)
The value of proteasome inhibition in cancer
Boris Cvek et al.
DRUG DISCOVERY TODAY (2008)
Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia
X. L. Zuo et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2006)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Exploiting the ubiquitin-proteasome pathway for anticancer drug discovery: Unanswered questions and future directions
DM Smith et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2005)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
Serum and tissue trace elements in patients with breast cancer in Taiwan
HW Kuo et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2002)
分享论文
